DE60132508D1 - Zusammensetzungen enthaltend Phytosterol- und Policosanolester von Fettsäuren zur Herabsetzung des Cholesterol- und Triglyceridspiegels - Google Patents

Zusammensetzungen enthaltend Phytosterol- und Policosanolester von Fettsäuren zur Herabsetzung des Cholesterol- und Triglyceridspiegels

Info

Publication number
DE60132508D1
DE60132508D1 DE60132508T DE60132508T DE60132508D1 DE 60132508 D1 DE60132508 D1 DE 60132508D1 DE 60132508 T DE60132508 T DE 60132508T DE 60132508 T DE60132508 T DE 60132508T DE 60132508 D1 DE60132508 D1 DE 60132508D1
Authority
DE
Germany
Prior art keywords
esters
mixture
ester
acid
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60132508T
Other languages
English (en)
Other versions
DE60132508T2 (de
Inventor
Endre Markovits Schersl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haerting S A
Original Assignee
Haerting S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haerting S A filed Critical Haerting S A
Application granted granted Critical
Publication of DE60132508D1 publication Critical patent/DE60132508D1/de
Publication of DE60132508T2 publication Critical patent/DE60132508T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
DE60132508T 2000-01-31 2001-01-30 Zusammensetzungen enthaltend Phytosterol- und Policosanolester von Fettsäuren zur Herabsetzung des Cholesterol- und Triglyceridspiegels Expired - Lifetime DE60132508T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CL2000000209 2000-01-31
CL2000209 2000-01-31

Publications (2)

Publication Number Publication Date
DE60132508D1 true DE60132508D1 (de) 2008-03-13
DE60132508T2 DE60132508T2 (de) 2008-04-30

Family

ID=38871703

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60132508T Expired - Lifetime DE60132508T2 (de) 2000-01-31 2001-01-30 Zusammensetzungen enthaltend Phytosterol- und Policosanolester von Fettsäuren zur Herabsetzung des Cholesterol- und Triglyceridspiegels

Country Status (6)

Country Link
US (1) US20020016314A1 (de)
EP (1) EP1121928B1 (de)
AT (1) ATE384518T1 (de)
DE (1) DE60132508T2 (de)
DK (1) DK1121928T3 (de)
ES (1) ES2298197T3 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6998501B1 (en) * 1999-08-30 2006-02-14 Ocean Nutrition Canada Limited Nutritional supplement for lowering serum triglyceride and cholesterol levels
WO2001015552A1 (en) * 1999-08-30 2001-03-08 Ocean Nutrition Canada Ltd. A nutritional supplement for lowering serum triglyceride and cholesterol levels
FI20012553A0 (fi) 2001-12-21 2001-12-21 Raisio Benecol Oy Syötävät koostumukset
IL147942A0 (en) * 2002-01-31 2002-08-14 Enzymotec Ltd Method of fractionation of phytosterol esters in oil and products obtained thereby
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
RU2331415C2 (ru) * 2002-06-17 2008-08-20 Медести Ресерч Энд Продакшн С.Р.Л. Длинноцепочечные ненасыщенные оксигенированные соединения и их применение в области терапии, косметики и питания
ES2209658B1 (es) * 2002-12-05 2005-10-01 Proyecto Empresarial Brudy, S.L. Utilizacion del acido docosahexaenoico como principio activo para el tratamiento de la lipodistrofia.
DE10261061A1 (de) * 2002-12-24 2004-07-15 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätetisches Lebensmittel zur positiven Beeinflussung der kardiovaskulären Gesundheit
US20060233863A1 (en) * 2003-02-10 2006-10-19 Enzymotec Ltd. Oils enriched with diacylglycerols and phytosterol esters and unit dosage forms thereof for use in therapy
WO2005023832A1 (en) * 2003-09-05 2005-03-17 University Of Nebraska-Lincoln Compound and method for enhancing the cholesterol lowering property of plant sterol and stanol esters
US20080182801A1 (en) * 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
GB0329667D0 (en) * 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
US20050163872A1 (en) * 2004-01-23 2005-07-28 Cargill, Incorporated Compositions and methods for reducing cholesterol
US20050281932A1 (en) * 2004-06-18 2005-12-22 Good Humor - Breyers Ice Cream Frozen confection
US20060009486A1 (en) * 2004-07-07 2006-01-12 Gm Pharmaceuticals Inc. Composition and method for treatment and prevention of coronary artery disease
US7615641B2 (en) 2004-07-20 2009-11-10 Sino Pharmaceuticals Corporation Long chain aliphatic alcohol derivatives and methods of making and using same
US20060020031A1 (en) * 2004-07-26 2006-01-26 Roger Berlin Compositions containing policosanol and omega-3 fatty acids and their pharmaceutical uses
US20060025486A1 (en) * 2004-07-27 2006-02-02 Roger Berlin Compositions containing policosanol and B vitamins and their pharmaceutical uses
US20060024383A1 (en) * 2004-07-27 2006-02-02 Roger Berlin Compositions containing policosanol and chromium and/or chromium salts and their pharmaceutical uses
JP2008509213A (ja) * 2004-08-09 2008-03-27 エンジモテック リミテッド 糖尿病患者のための食物製品
WO2006016363A2 (en) 2004-08-10 2006-02-16 Enzymotec Ltd. Mixture of phytosterol ester(s) and 1, 3-diglyceride(s) for use in the treatment of medical conditions
GB0512726D0 (en) * 2005-06-22 2005-07-27 Btg Int Ltd Multiple sclerosis therapy and diagnosis
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
US20070020340A1 (en) * 2005-07-25 2007-01-25 David Rubin Fish oil products for reducing cholesterol, low density lipoprotein, and hypertension
US7678399B2 (en) 2005-12-05 2010-03-16 Bunge Oils, Inc. Phytosterol containing deep-fried foods and methods with health promoting characteristics
US8202541B2 (en) * 2006-02-07 2012-06-19 U.S. Nutraceuticals, LLC Dietary supplement composition for blood lipid health
US8017153B2 (en) * 2006-02-07 2011-09-13 U.S. Nutraceuticals, LLC Dietary supplement composition for blood lipid health
CN101646426A (zh) * 2006-11-03 2010-02-10 普罗诺瓦生物医药挪威公司 ω-3脂质化合物
US7794758B2 (en) * 2007-04-05 2010-09-14 Pmc Formulas, Inc. Compounds and methods for promoting cellular health and treatment of cancer
US8394425B2 (en) * 2007-04-05 2013-03-12 Pmc Formulas, Inc. Methods for promoting cellular health and treatment of cancer
ES2334313B1 (es) * 2008-05-16 2011-01-24 Universidad Autonoma De Madrid Procedimiento supercritico y enzimatico para obtener nuevos esteres de esteroles.
KR101294970B1 (ko) * 2011-06-30 2013-08-09 고려대학교 산학협력단 폴리코사놀 에스터, 이의 제조 방법 및 이를 포함하는 첨가제

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031376A (en) * 1956-10-11 1962-04-24 Levin Compositions comprising octacosanol, triacontanol, tetracosanol, or hexacosanol, andmethods employing same
JPS6299323A (ja) * 1985-10-25 1987-05-08 Yoshihide Hagiwara 高脂血症剤
JPS62224258A (ja) * 1986-03-25 1987-10-02 Jun Kawai 栄養食品
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
RU2095367C1 (ru) * 1991-05-03 1997-11-10 Райсион Техтаат ой АБ Вещество, понижающее уровень холестерина в сыворотке крови, и способ его получения
GB9300125D0 (en) * 1993-01-06 1993-03-03 Scotia Holdings Plc Compositions containing esters of unsaturated fatty acids
CN1103586C (zh) * 1993-12-13 2003-03-26 里达克药品公司 蔗糖酯－c20－28醇制剂
FI107015B (fi) * 1996-08-09 2001-05-31 Raisio Benecol Oy Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike
US5952393A (en) * 1998-02-12 1999-09-14 Sorkin, Jr.; Harlan Lee Composition for reducing serum cholesterol levels
WO2000061771A2 (en) * 1999-04-12 2000-10-19 Monsanto Technology Llc Transgenic plants containing altered levels of sterol compounds and tocopherols

Also Published As

Publication number Publication date
US20020016314A1 (en) 2002-02-07
ATE384518T1 (de) 2008-02-15
DE60132508T2 (de) 2008-04-30
EP1121928B1 (de) 2008-01-23
EP1121928A1 (de) 2001-08-08
DK1121928T3 (da) 2008-03-17
ES2298197T3 (es) 2008-05-16

Similar Documents

Publication Publication Date Title
DE60132508D1 (de) Zusammensetzungen enthaltend Phytosterol- und Policosanolester von Fettsäuren zur Herabsetzung des Cholesterol- und Triglyceridspiegels
KR100684642B1 (ko) 어유 유래 글리세라이드 유지 조성물 및 이의 제조방법
JP4530311B2 (ja) リパーゼを用いたグリセライドの製造方法
US6537787B1 (en) Enzymatic methods for polyunsaturated fatty acid enrichment
NZ608755A (en) Plant support formulation, vehicle for the delivery and translocation of phytologically beneficial substances and compositions containing same
ATE102834T1 (de) Fettemulsion, verfahren zu ihrer herstellung und ihre verwendung.
ATE211126T1 (de) Verfahren zur herstellung synthetischer triglyceride auf basis konjugierter linolsäure
DK1682226T3 (da) Lipidpræparat til forbedring af mineralabsorption
ATE216230T1 (de) Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen
ATE475416T1 (de) Fettalkohole und fettsäureester zur behandlung von entzündungen
NO990739D0 (no) Lipase-katalysert esterifikasjon av marine oljer
DE69417726T2 (de) Verfahren zur Herstellung eines Konzentrates von Estern von mehrfach ungesättigten Fettsäuren
WO2008133573A1 (en) A polyunsaturated fatty acid (pufa) enriched marine oil comprising eicosapentaenoic acid (epa) and docosahexaenoic acid (dha), and a process of production thereof
DE69328618T2 (de) Medikamente auf der Basis von Docosahexaensäure, als Plättchenaggregationshemmer und gegen cerebralen Mangel an Fettsäuren, und Verfahren zur Herstellung.
DK1476171T3 (da) Transport af nukleinsyresubstanser
JPH0789944B2 (ja) 製菓用油脂組成物の製法
DE69510749T2 (de) Verfahren zur Herstellung von durch Fettsäuren verestertem propoxyliertem Glycerin
ATE531389T1 (de) Lipid- und distickstoffoxidverbindung als hilfsmittel zur erhöhung der impfstoffeffizienz
JP4079516B2 (ja) トリグリセリドの製造方法
MXPA01007680A (es) Procedimiento para obtener un aceite que es enriquecido en acidos grasos hidroxioctadecadienoicos (hode) o esteres de los mismos a partir de una mezcla oleosa que contiene acido linoleico o esteres del mismo.
JP2008127399A (ja) 油脂の固液分離防止剤
MXPA05005316A (es) Saponificacion de sal de calcio de aceites poliinsaturados.
JPH09313104A (ja) フライ用油脂
KR20240043414A (ko) 저온결정법과 에스테르 반응을 이용한 오메가­３ 불포화지방산의 효율적인 농축방법
JPS63313591A (ja) 油脂の加水分解方法

Legal Events

Date Code Title Description
8364 No opposition during term of opposition